Georgia's Online Cancer Information Center

Find A Clinical Trial

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Status
Active
Cancer Type
Liver Cancer / Hepatoblastoma
Trial Phase
Eligibility
18 Years and older, Male and Female
Study Type
Other
NCT ID
NCT02954094
Protocol IDs
TARGET-HCC (primary)
NCI-2018-00316
Study Sponsor
Target PharmaSolutions, Inc.

Summary

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in
usual clinical practice. TARGET-HCC will create a research registry of participants with
HCC within academic and community real-world practices in order to assess the safety and
effectiveness of the entire spectrum of current and future therapies across diverse
populations.

Eligibility

  1. Male or female patients, age =18 years
  2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)

Treatment Sites in Georgia

Emory University Hospital - Atlanta


1364 Clifton Road NE
Atlanta, GA 30322
www.emoryhealthcare.org

Piedmont Hospital - Atlanta


1968 Peachtree Road, NW
Atlanta, GA 30309
www.piedmont.org

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.